Targeted Drugs for NSCLC Market Report

2023 Global Targeted Drugs for NSCLC Market Analysis Report, Key Competitors, Market Effect Factors, Growth, And Forecast

  • POSTDATE：Mar 07, 2023
  • PAGES：168
  • REPORT CODE：GMM1550552
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Targeted Drugs for NSCLC market size is expected to gain market growth in the forecast period of 2023 to 2028, with a CAGR of XX in the forecast period of 2023 to 2028 and will be expected to reach USD XX million by 2028, from USD XX million in 2023.

    The Targeted Drugs for NSCLC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

    This report also includes the impact of The COVID-19 outbreak on the Targeted Drugs for NSCLC industry, involving potential opportunity and challenges, drivers, and risks. We present the impact assessment of COVID-19 effects on Targeted Drugs for NSCLC and market growth forecast based on different scenarios (optimistic, pessimistic, very optimistic, most likely, etc.).


    Market Segmentation by Company

    • BeiGene

    • Pfizer

    • Amgen

    • AstraZeneca

    • Cipla

    • Glenmark Pharmaceuticals

    • Reliance Lifesciences

    • Natco Pharma

    • Incepta Pharmaceuticals

    • Beacon Pharma Limited

    • Mylan

    • Biocon

    • Genvio Pharma Limited

    • Allergan

    • Roche

    • Novartis

    • ARIAD Pharmaceuticals (Takeda)

    • Hetero Drugs

    • Teva

    • ImClone Systems ‎(Eli Lilly)

    • OSI Pharmaceuticals

    • Boehringer-Ingelheim

    • Fujifilm Kyowa Kirin Biologics

    • Drug International Limted

    • Celgene Corporation


    Market Segmentation by Classification

    • Target EGFR

    • Target ALK

    • Target HER2

    • Target ROS1

    • Target BRAF

    • Target MEK

    • Target VEGFR2

    • Target VEGF

    • Target MET


    Market Segmentation by End-Users

    • Squamous Cell Carcinoma of NSCLC

    • Adenocarcinoma of NSCLC

    • Large Cell Carcinoma of NSCLC


    Market Segmentation by Geography

    North America

    • USA

    • Canada

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Southeast Asia

    Middle East

    • Saudi Arabia

    • United Arab Emirates

    • Iraq

    • Qatar

    • Kuwait

    Africa

    • Egypt

    • Algeria

    • Morocco

    • South Africa

    • Libya

    Latin America and the Caribbean

    • Mexico

    • Brazil

    • Argentina

    • Colombia

    • Chile

    Oceania

    • Australia

    • New Zealand


    Key Benefits for Stakeholders

    The report provides a quantitative analysis of the current Targeted Drugs for NSCLC market trends, estimations, and dynamics of the market size from 2023 to 2028 to identify the prevailing opportunities.

    Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.

    In-depth Targeted Drugs for NSCLC market analysis and the market size and segmentation assist to determine the prevailing Targeted Drugs for NSCLC market opportunities.

    The major countries in each region are mapped according to their revenue contribution to the market.

    The market player positioning segment facilitates benchmarking and provides a clear understanding of the present position of the market players in the Targeted Drugs for NSCLC industry.

  • TABLE OF CONTENTS

    Chapter 1 Targeted Drugs for NSCLC Market Overview

    • 1.1 Targeted Drugs for NSCLC Market Development Introduction

    • 1.2 Targeted Drugs for NSCLC Market Overlook, by Classification

    • 1.3 Targeted Drugs for NSCLC Market Overlook, by End-Users

    Chapter 2 Market Dynamics

    • 2.1 Market News and Trend

      • 2.1.1 Merger & Acquisition

      • 2.1.2 New Product Launch

    • 2.2 Investment Environment

      • 2.2.1 Investment Attractiveness of Regions (Key Region Analysis)

      • 2.2.2 Strategy and Suggestions on New Project Investment

    • 2.3 Impact of COVID-19 on the Targeted Drugs for NSCLC Industry

      • 2.3.1 COVID-19 Outbreak Distribution by Region

      • 2.3.2 Impact on Targeted Drugs for NSCLC Industry Upstream

      • 2.3.3 Impact on Targeted Drugs for NSCLC Industry Channels

      • 2.3.4 Impact on Targeted Drugs for NSCLC Industry Downstream

      • 2.3.5 Impact on Targeted Drugs for NSCLC Industry Competition

      • 2.3.6 Impact on Targeted Drugs for NSCLC Industry Employment

    Chapter 3 Market Industry Chain Analysis

    • 3.1 Targeted Drugs for NSCLC Market Industry Chain Analysis

      • 3.1.1 Upstream

      • 3.1.2 Market Channel

      • 3.1.3 Targeted Drugs for NSCLC Market, by End- User

      • 3.1.4 Consumer Needs/Customer Preference Change

    • 3.2 Porters Five Force Analysis

      • 3.2.1 Threat of New Entrants

      • 3.2.2 Bargaining Power of Suppliers

      • 3.2.3 Bargaining Power of Buyers

      • 3.2.4 Threat of Substitutes

      • 3.2.5 Intensity of Rivalry

    Chapter 4 Global Market Overview

    • 4.1 2018-2028 Global Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

    • 4.2 2018-2023 Global Targeted Drugs for NSCLC Market Consumption, Value, Price by Geography

      • 4.2.1 North America

      • 4.2.2 Europe

      • 4.2.3 Asia

      • 4.2.4 Africa

      • 4.2.5 Middle East

      • 4.2.6 Latin America and the Caribbean

      • 4.2.7 Oceania

    • 4.3 2018-2023 Global Targeted Drugs for NSCLC Market Consumption, Value, Price by Classification

      • 4.3.1 2018-2023 Target EGFR Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 4.3.2 2018-2023 Target ALK Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 4.3.3 2018-2023 Target HER2 Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 4.3.4 2018-2023 Target ROS1 Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 4.3.5 2018-2023 Target BRAF Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 4.3.6 2018-2023 Target MEK Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 4.3.7 2018-2023 Target VEGFR2 Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 4.3.8 2018-2023 Target VEGF Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 4.3.9 2018-2023 Target MET Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

    • 4.4 2018-2023 Global Targeted Drugs for NSCLC Market Consumption, Value, Price by End-Users

      • 4.4.1 2018-2023 Squamous Cell Carcinoma of NSCLC Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 4.4.2 2018-2023 Adenocarcinoma of NSCLC Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 4.4.3 2018-2023 Large Cell Carcinoma of NSCLC Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

    Chapter 5 Geography Analysis

    • 5.1 2018-2023 North America Targeted Drugs for NSCLC Market Consumption, Value by Country

      • 5.1.1 2018-2023 USA Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.1.2 2018-2023 Canada Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

    • 5.2 2018-2023 Europe Targeted Drugs for NSCLC Market Consumption, Value by Country

      • 5.2.1 2018-2023 Germany Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.2.2 2018-2023 United Kingdom Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.2.3 2018-2023 France Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.2.4 2018-2023 Italy Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.2.5 2018-2023 Russia Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.2.6 2018-2023 Spain Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.2.7 2018-2023 Netherlands Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.2.8 2018-2023 Switzerland Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.2.9 2018-2023 Turkey Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.2.10 2018-2023 Poland Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

    • 5.3 2018-2023 Asia Targeted Drugs for NSCLC Market Consumption, Value by Country

      • 5.3.1 2018-2023 China Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.3.2 2018-2023 Japan Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.3.3 2018-2023 India Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.3.4 2018-2023 South Korea Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.3.5 2018-2023 Southeast Asia Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

    • 5.4 2018-2023 Africa Targeted Drugs for NSCLC Market Consumption, Value by Country

      • 5.4.1 2018-2023 Egypt Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.4.2 2018-2023 Algeria Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.4.3 2018-2023 Morocco Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.4.4 2018-2023 South Africa Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.4.5 2018-2023 Libya Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

    • 5.5 2018-2023 Middle East Targeted Drugs for NSCLC Market Consumption, Value by Country

      • 5.5.1 2018-2023 Saudi Arabia Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.5.2 2018-2023 United Arab Emirates Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.5.3 2018-2023 Iraq Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.5.4 2018-2023 Qatar Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.5.5 2018-2023 Kuwait Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

    • 5.6 2018-2023 Latin America and the Caribbean Targeted Drugs for NSCLC Market Consumption, Value by Country

      • 5.6.1 2018-2023 Mexico Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.6.2 2018-2023 Brazil Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.6.3 2018-2023 Argentina Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.6.4 2018-2023 Colombia Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.6.5 2018-2023 Chile Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

    • 5.7 2018-2023 Oceania Targeted Drugs for NSCLC Market Consumption, Value by Country

      • 5.7.1 2018-2023 Australia Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 5.7.2 2018-2023 New Zealand Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

    Chapter 6 North America Geography Trend

    • 6.1 Key Forces Shaping/Hindering North America Targeted Drugs for NSCLC Market

    • 6.2 2023-2028 North America Targeted Drugs for NSCLC Market Consumption, Value Trend, by Country

      • 6.2.1 2023-2028 USA Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 6.2.2 2023-2028 Canada Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

    Chapter 7 Europe Geography Trend

    • 7.1 Key Forces Shaping/Hindering Europe Targeted Drugs for NSCLC Market

    • 7.2 2023-2028 Europe Targeted Drugs for NSCLC Market Consumption, Value Trend, by Country

      • 7.2.1 2023-2028 Germany Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 7.2.2 2023-2028 United Kingdom Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 7.2.3 2023-2028 France Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 7.2.4 2023-2028 Italy Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 7.2.5 2023-2028 Russia Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 7.2.6 2023-2028 Spain Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 7.2.7 2023-2028 Netherlands Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 7.2.8 2023-2028 Switzerland Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 7.2.9 2023-2028 Turkey Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 7.2.10 2023-2028 Poland Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

    Chapter 8 Asia Geography Trend

    • 8.1 Key Forces Shaping/Hindering Asia Targeted Drugs for NSCLC Market

    • 8.2 2023-2028 Asia Targeted Drugs for NSCLC Market Consumption, Value Trend, by Country

      • 8.2.1 2023-2028 China Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 8.2.2 2023-2028 Japan Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 8.2.3 2023-2028 India Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 8.2.4 2023-2028 South Korea Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 8.2.5 2023-2028 Southeast Asia Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

    Chapter 9 Africa Geography Trend

    • 9.1 Key Forces Shaping/Hindering Africa Targeted Drugs for NSCLC Market

    • 9.2 2023-2028 Africa Targeted Drugs for NSCLC Market Consumption, Value Trend, by Country

      • 9.2.1 2023-2028 Egypt Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 9.2.2 2023-2028 Algeria Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 9.2.3 2023-2028 Morocco Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 9.2.4 2023-2028 South Africa Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 9.2.5 2023-2028 Libya Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

    Chapter 10 Middle East Geography Trend

    • 10.1 Key Forces Shaping/Hindering Middle East Targeted Drugs for NSCLC Market

    • 10.2 2023-2028 Middle East Targeted Drugs for NSCLC Market Consumption, Value Trend, by Country

      • 10.2.1 2023-2028 Saudi Arabia Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 10.2.2 2023-2028 United Arab Emirates Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 10.2.3 2023-2028 Iraq Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 10.2.4 2023-2028 Qatar Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 10.2.5 2023-2028 Kuwait Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

    Chapter 11 Latin America and the Caribbean Geography Trend

    • 11.1 Key Forces Shaping/Hindering Latin America and the Caribbean Targeted Drugs for NSCLC Market

    • 11.2 2023-2028 Latin America and the Caribbean Targeted Drugs for NSCLC Market Consumption, Value Trend, by Country

      • 11.2.1 2023-2028 Mexico Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 11.2.2 2023-2028 Brazil Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 11.2.3 2023-2028 Argentina Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 11.2.4 2023-2028 Chile Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

    Chapter 12 Oceania Geography Trend

    • 12.1 Key Forces Shaping/Hindering Oceania Targeted Drugs for NSCLC Market

    • 12.2 2023-2028 Oceania Targeted Drugs for NSCLC Market Consumption, Value Trend, by Country

      • 12.2.1 2023-2028 Australia Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

      • 12.2.2 2023-2028 New Zealand Targeted Drugs for NSCLC Market Consumption, Value and Growth Rate

    Chapter 13 Classification and End-User Trend Analysis

    • 13.1 2023-2028 Global Targeted Drugs for NSCLC Market Consumption, Value, Price by Classification

      • 13.1.1 2023-2028 Target EGFR Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 13.1.2 2023-2028 Target ALK Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 13.1.3 2023-2028 Target HER2 Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 13.1.4 2023-2028 Target ROS1 Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 13.1.5 2023-2028 Target BRAF Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 13.1.6 2023-2028 Target MEK Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 13.1.7 2023-2028 Target VEGFR2 Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 13.1.8 2023-2028 Target VEGF Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 13.1.9 2023-2028 Target MET Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

    • 13.2 2023-2028 Global Targeted Drugs for NSCLC Market Consumption, Value, Price, by End-Users

      • 13.2.1 2023-2028 Squamous Cell Carcinoma of NSCLC Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 13.2.2 2023-2028 Adenocarcinoma of NSCLC Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

      • 13.2.3 2023-2028 Large Cell Carcinoma of NSCLC Consumption, Value and Growth Rate of Global Targeted Drugs for NSCLC Market

    Chapter 14 Geography Import & Export

    • 14.1 Global Targeted Drugs for NSCLC Market Import by Geography

    • 14.2 Global Targeted Drugs for NSCLC Market Export by Geography

    Chapter 15 Targeted Drugs for NSCLC - Company List

      • 15.1 BeiGene

        • 15.1.1 BeiGene - Company Snapshot

        • 15.1.2 Business Operation

        • 15.1.3 BeiGene - Company Products Benchmarking

        • 15.1.4 Key Strategic Moves and Developments

      • 15.2 Pfizer

        • 15.2.1 Pfizer - Company Snapshot

        • 15.2.2 Business Operation

        • 15.2.3 Pfizer - Company Products Benchmarking

        • 15.2.4 Key Strategic Moves and Developments

      • 15.3 Amgen

        • 15.3.1 Amgen - Company Snapshot

        • 15.3.2 Business Operation

        • 15.3.3 Amgen - Company Products Benchmarking

        • 15.3.4 Key Strategic Moves and Developments

      • 15.4 AstraZeneca

        • 15.4.1 AstraZeneca - Company Snapshot

        • 15.4.2 Business Operation

        • 15.4.3 AstraZeneca - Company Products Benchmarking

        • 15.4.4 Key Strategic Moves and Developments

      • 15.5 Cipla

        • 15.5.1 Cipla - Company Snapshot

        • 15.5.2 Business Operation

        • 15.5.3 Cipla - Company Products Benchmarking

        • 15.5.4 Key Strategic Moves and Developments

      • 15.6 Glenmark Pharmaceuticals

        • 15.6.1 Glenmark Pharmaceuticals - Company Snapshot

        • 15.6.2 Business Operation

        • 15.6.3 Glenmark Pharmaceuticals - Company Products Benchmarking

        • 15.6.4 Key Strategic Moves and Developments

      • 15.7 Reliance Lifesciences

        • 15.7.1 Reliance Lifesciences - Company Snapshot

        • 15.7.2 Business Operation

        • 15.7.3 Reliance Lifesciences - Company Products Benchmarking

        • 15.7.4 Key Strategic Moves and Developments

      • 15.8 Natco Pharma

        • 15.8.1 Natco Pharma - Company Snapshot

        • 15.8.2 Business Operation

        • 15.8.3 Natco Pharma - Company Products Benchmarking

        • 15.8.4 Key Strategic Moves and Developments

      • 15.9 Incepta Pharmaceuticals

        • 15.9.1 Incepta Pharmaceuticals - Company Snapshot

        • 15.9.2 Business Operation

        • 15.9.3 Incepta Pharmaceuticals - Company Products Benchmarking

        • 15.9.4 Key Strategic Moves and Developments

      • 15.10 Beacon Pharma Limited

        • 15.10.1 Beacon Pharma Limited - Company Snapshot

        • 15.10.2 Business Operation

        • 15.10.3 Beacon Pharma Limited - Company Products Benchmarking

        • 15.10.4 Key Strategic Moves and Developments

      • 15.11 Mylan

        • 15.11.1 Mylan - Company Snapshot

        • 15.11.2 Business Operation

        • 15.11.3 Mylan - Company Products Benchmarking

        • 15.11.4 Key Strategic Moves and Developments

      • 15.12 Biocon

        • 15.12.1 Biocon - Company Snapshot

        • 15.12.2 Business Operation

        • 15.12.3 Biocon - Company Products Benchmarking

        • 15.12.4 Key Strategic Moves and Developments

      • 15.13 Genvio Pharma Limited

        • 15.13.1 Genvio Pharma Limited - Company Snapshot

        • 15.13.2 Business Operation

        • 15.13.3 Genvio Pharma Limited - Company Products Benchmarking

        • 15.13.4 Key Strategic Moves and Developments

      • 15.14 Allergan

        • 15.14.1 Allergan - Company Snapshot

        • 15.14.2 Business Operation

        • 15.14.3 Allergan - Company Products Benchmarking

        • 15.14.4 Key Strategic Moves and Developments

      • 15.15 Roche

        • 15.15.1 Roche - Company Snapshot

        • 15.15.2 Business Operation

        • 15.15.3 Roche - Company Products Benchmarking

        • 15.15.4 Key Strategic Moves and Developments

      • 15.16 Novartis

        • 15.16.1 Novartis - Company Snapshot

        • 15.16.2 Business Operation

        • 15.16.3 Novartis - Company Products Benchmarking

        • 15.16.4 Key Strategic Moves and Developments

      • 15.17 ARIAD Pharmaceuticals (Takeda)

        • 15.17.1 ARIAD Pharmaceuticals (Takeda) - Company Snapshot

        • 15.17.2 Business Operation

        • 15.17.3 ARIAD Pharmaceuticals (Takeda) - Company Products Benchmarking

        • 15.17.4 Key Strategic Moves and Developments

      • 15.18 Hetero Drugs

        • 15.18.1 Hetero Drugs - Company Snapshot

        • 15.18.2 Business Operation

        • 15.18.3 Hetero Drugs - Company Products Benchmarking

        • 15.18.4 Key Strategic Moves and Developments

      • 15.19 Teva

        • 15.19.1 Teva - Company Snapshot

        • 15.19.2 Business Operation

        • 15.19.3 Teva - Company Products Benchmarking

        • 15.19.4 Key Strategic Moves and Developments

      • 15.20 ImClone Systems ‎(Eli Lilly)

        • 15.20.1 ImClone Systems ‎(Eli Lilly) - Company Snapshot

        • 15.20.2 Business Operation

        • 15.20.3 ImClone Systems ‎(Eli Lilly) - Company Products Benchmarking

        • 15.20.4 Key Strategic Moves and Developments

      • 15.21 OSI Pharmaceuticals

        • 15.21.1 OSI Pharmaceuticals - Company Snapshot

        • 15.21.2 Business Operation

        • 15.21.3 OSI Pharmaceuticals - Company Products Benchmarking

        • 15.21.4 Key Strategic Moves and Developments

      • 15.22 Boehringer-Ingelheim

        • 15.22.1 Boehringer-Ingelheim - Company Snapshot

        • 15.22.2 Business Operation

        • 15.22.3 Boehringer-Ingelheim - Company Products Benchmarking

        • 15.22.4 Key Strategic Moves and Developments

      • 15.23 Fujifilm Kyowa Kirin Biologics

        • 15.23.1 Fujifilm Kyowa Kirin Biologics - Company Snapshot

        • 15.23.2 Business Operation

        • 15.23.3 Fujifilm Kyowa Kirin Biologics - Company Products Benchmarking

        • 15.23.4 Key Strategic Moves and Developments

      • 15.24 Drug International Limted

        • 15.24.1 Drug International Limted - Company Snapshot

        • 15.24.2 Business Operation

        • 15.24.3 Drug International Limted - Company Products Benchmarking

        • 15.24.4 Key Strategic Moves and Developments

      • 15.25 Celgene Corporation

        • 15.25.1 Celgene Corporation - Company Snapshot

        • 15.25.2 Business Operation

        • 15.25.3 Celgene Corporation - Company Products Benchmarking

        • 15.25.4 Key Strategic Moves and Developments

    Chapter 16 Global Targeted Drugs for NSCLC Market Competition

    • 16.1 Global Targeted Drugs for NSCLC Market Key Players Competition

    • 16.2 Global Targeted Drugs for NSCLC Market Concentration

    • 16.3 Market Strategy Analysis for Large Companies and Startups/ SMEs

    Chapter 17 Key Findings and Conclusion

    The List of Tables and Figures (Totals 113 Figures and 187 Tables)

    • Table Targeted Drugs for NSCLC Market Development Introduction

    • Figure 2018-2028 Targeted Drugs for NSCLC Market Size, by Classification

    • Table Targeted Drugs for NSCLC Market Profile, by Classification

    • Figure 2018-2028 Targeted Drugs for NSCLC Market Size, by End-Users

    • Table Targeted Drugs for NSCLC Market Profile, by End-Users

    • Table Merger & Acquisition

    • Table New Product Launch

    • Table Investment Attractiveness of Regions (Key Region Analysis)

    • Table Strategy and Suggestions on New Project Investment

    • Figure COVID-19 Latest Data Presentation

    • Figure Targeted Drugs for NSCLC Market Industry Chain

    • Table Raw Material Introduction

    • Table Raw Material Market Distribution and Price Trend

    • Figure Targeted Drugs for NSCLC Market Channel Model

    • Table Targeted Drugs for NSCLC Market, by Distributor, Trader, Retailer

    • Table Targeted Drugs for NSCLC Market, by End- User

    • Table Consumer Needs/Customer Preference Change

    • Figure Porter’s Five Forces Model

    • Figure 2018-2028 Global Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2028 Global Targeted Drugs for NSCLC Market Value and Growth Rate

    • Table 2018-2023 Global Targeted Drugs for NSCLC Market Consumption, by Geography

    • Table 2018-2023 Global Targeted Drugs for NSCLC Market Value, by Geography

    • Table 2018-2023 Global Targeted Drugs for NSCLC Market Price, by Geography

    • Figure 2018-2023 North America Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 North America Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Europe Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Europe Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Asia Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Asia Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Africa Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Africa Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Middle East Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Middle East Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Latin America and the Caribbean Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Latin America and the Caribbean Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Oceania Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Oceania Targeted Drugs for NSCLC Market Value and Growth Rate

    • Table 2018-2023 Global Targeted Drugs for NSCLC Market Consumption, by Classification

    • Table 2018-2023 Global Targeted Drugs for NSCLC Market Value, by Classification

    • Table 2018-2023 Global Targeted Drugs for NSCLC Market Price, by Classification

    • Figure 2018-2023 Target EGFR Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2018-2023 Target ALK Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2018-2023 Target HER2 Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2018-2023 Target ROS1 Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2018-2023 Target BRAF Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2018-2023 Target MEK Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2018-2023 Target VEGFR2 Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2018-2023 Target VEGF Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2018-2023 Target MET Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Table 2018-2023 Global Targeted Drugs for NSCLC Market Consumption, by End-Users

    • Table 2018-2023 Global Targeted Drugs for NSCLC Market Value, by End-Users

    • Table 2018-2023 Global Targeted Drugs for NSCLC Market Price, by End-Users

    • Figure Squamous Cell Carcinoma of NSCLC Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure Adenocarcinoma of NSCLC Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure Large Cell Carcinoma of NSCLC Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Table 2018-2023 North America Targeted Drugs for NSCLC Market Consumption, by Country

    • Table 2018-2023 North America Targeted Drugs for NSCLC Market Value, by Country

    • Figure 2018-2023 USA Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 USA Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Canada Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Canada Targeted Drugs for NSCLC Market Value and Growth Rate

    • Table 2018-2023 Europe Targeted Drugs for NSCLC Market Consumption, by Country

    • Table 2018-2023 Europe Targeted Drugs for NSCLC Market Value, by Country

    • Figure 2018-2023 Germany Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Germany Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 United Kingdom Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 United Kingdom Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 France Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 France Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Italy Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Italy Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Russia Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Russia Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Spain Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Spain Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Netherlands Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Netherlands Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Switzerland Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Switzerland Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Turkey Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Turkey Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Poland Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Poland Targeted Drugs for NSCLC Market Value and Growth Rate

    • Table 2018-2023 Asia Targeted Drugs for NSCLC Market Consumption, by Country

    • Table 2018-2023 Asia Targeted Drugs for NSCLC Market Value, by Country

    • Figure 2018-2023 China Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 China Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Japan Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Japan Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 India Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 India Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 South Korea Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 South Korea Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Southeast Asia Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Southeast Asia Targeted Drugs for NSCLC Market Value and Growth Rate

    • Table 2018-2023 Africa Targeted Drugs for NSCLC Market Consumption, by Country

    • Table 2018-2023 Africa Targeted Drugs for NSCLC Market Value, by Country

    • Figure 2018-2023 Egypt Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Egypt Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Algeria Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Algeria Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Morocco Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Morocco Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 South Africa Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 South Africa Targeted Drugs for NSCLC Market Value and Growth Rate

    • Table 2018-2023 Middle East Targeted Drugs for NSCLC Market Consumption, by Country

    • Table 2018-2023 Middle East Targeted Drugs for NSCLC Market Value, by Country

    • Figure 2018-2023 Saudi Arabia Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Saudi Arabia Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 United Arab Emirates Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 United Arab Emirates Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Iraq Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Iraq Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Qatar Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Qatar Targeted Drugs for NSCLC Market Value and Growth Rate

    • Table 2018-2023 Latin America and the Caribbean Targeted Drugs for NSCLC Market Consumption, by Country

    • Table 2018-2023 Latin America and the Caribbean Targeted Drugs for NSCLC Market Value, by Country

    • Figure 2018-2023 Mexico Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Mexico Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Brazil Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Brazil Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Argentina Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Argentina Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Colombia Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Colombia Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 Chile Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Chile Targeted Drugs for NSCLC Market Value and Growth Rate

    • Table 2018-2023 Oceania Targeted Drugs for NSCLC Market Consumption, by Country

    • Table 2018-2023 Oceania Targeted Drugs for NSCLC Market Value, by Country

    • Figure 2018-2023 Australia Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 Australia Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2018-2023 New Zealand Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2018-2023 New Zealand Targeted Drugs for NSCLC Market Value and Growth Rate

    • Table Key Forces Shaping/Hindering North America Targeted Drugs for NSCLC Market

    • Table 2023-2028 North America Targeted Drugs for NSCLC Market Consumption Trend, by Country

    • Table 2023-2028 North America Targeted Drugs for NSCLC Market Value Trend, by Country

    • Figure 2023-2028 USA Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 USA Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Canada Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Canada Targeted Drugs for NSCLC Market Value and Growth Rate

    • Table Key Forces Shaping/Hindering Europe Targeted Drugs for NSCLC Market

    • Table 2023-2028 Europe Targeted Drugs for NSCLC Market Consumption Trend, by Country

    • Table 2023-2028 Europe Targeted Drugs for NSCLC Market Value Trend, by Country

    • Figure 2023-2028 Germany Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Germany Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 United Kingdom Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 United Kingdom Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 France Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 France Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Italy Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Italy Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Russia Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Russia Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Spain Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Spain Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Netherlands Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Netherlands Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Switzerland Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Switzerland Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Turkey Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Turkey Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Poland Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Poland Targeted Drugs for NSCLC Market Value and Growth Rate

    • Table Key Forces Shaping/Hindering Asia Targeted Drugs for NSCLC Market

    • Table 2023-2028 Asia Targeted Drugs for NSCLC Market Consumption Trend, by Country

    • Table 2023-2028 Asia Targeted Drugs for NSCLC Market Value Trend, by Country

    • Figure 2023-2028 China Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 China Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Japan Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Japan Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 India Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 India Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 South Korea Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 South Korea Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Southeast Asia Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Southeast Asia Targeted Drugs for NSCLC Market Value and Growth Rate

    • Table Key Forces Shaping/Hindering Africa Targeted Drugs for NSCLC Market

    • Table 2023-2028 Africa Targeted Drugs for NSCLC Market Consumption Trend, by Country

    • Table 2023-2028 Africa Targeted Drugs for NSCLC Market Value Trend, by Country

    • Figure 2023-2028 Egypt Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Egypt Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Algeria Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Algeria Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Morocco Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Morocco Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 South Africa Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 South Africa Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Libya Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Libya Targeted Drugs for NSCLC Market Value and Growth Rate

    • Table Key Forces Shaping/Hindering Middle East Targeted Drugs for NSCLC Market

    • Table 2023-2028 Middle East Targeted Drugs for NSCLC Market Consumption Trend, by Country

    • Table 2023-2028 Middle East Targeted Drugs for NSCLC Market Value Trend, by Country

    • Figure 2023-2028 Saudi Arabia Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Saudi Arabia Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 United Arab Emirates Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 United Arab Emirates Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Iraq Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Iraq Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Qatar Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Qatar Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Kuwait Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Kuwait Targeted Drugs for NSCLC Market Value and Growth Rate

    • Table Key Forces Shaping/Hindering Latin America and the Caribbean Targeted Drugs for NSCLC Market

    • Table 2023-2028 Latin America and the Caribbean Targeted Drugs for NSCLC Market Consumption Trend, by Country

    • Table 2023-2028 Latin America and the Caribbean Targeted Drugs for NSCLC Market Value Trend, by Country

    • Figure 2023-2028 Mexico Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Mexico Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Brazil Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Brazil Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Argentina Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Argentina Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 Chile Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Chile Targeted Drugs for NSCLC Market Value and Growth Rate

    • Table Key Forces Shaping/Hindering Oceania Targeted Drugs for NSCLC Market

    • Table 2023-2028 Oceania Targeted Drugs for NSCLC Market Consumption Trend, by Country

    • Table 2023-2028 Oceania Targeted Drugs for NSCLC Market Value Trend, by Country

    • Figure 2023-2028 Australia Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 Australia Targeted Drugs for NSCLC Market Value and Growth Rate

    • Figure 2023-2028 New Zealand Targeted Drugs for NSCLC Market Consumption and Growth Rate

    • Figure 2023-2028 New Zealand Targeted Drugs for NSCLC Market Value and Growth Rate

    • Table 2023-2028 Global Targeted Drugs for NSCLC Market Consumption Trend, by Classification

    • Table 2023-2028 Global Targeted Drugs for NSCLC Market Value Trend, by Classification

    • Table 2023-2028 Global Targeted Drugs for NSCLC Market Price Trend, by Classification

    • Figure 2023-2028 Target EGFR Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2023-2028 Target ALK Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2023-2028 Target HER2 Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2023-2028 Target ROS1 Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2023-2028 Target BRAF Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2023-2028 Target MEK Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2023-2028 Target VEGFR2 Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2023-2028 Target VEGF Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2023-2028 Target MET Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Table 2023-2028 Global Targeted Drugs for NSCLC Market Consumption Trend, by End-Users

    • Table 2023-2028 Global Targeted Drugs for NSCLC Market Value Trend, by End-Users

    • Table 2023-2028 Global Targeted Drugs for NSCLC Market Price Trend, by End-Users

    • Figure 2023-2028 Squamous Cell Carcinoma of NSCLC Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2023-2028 Adenocarcinoma of NSCLC Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Figure 2023-2028 Large Cell Carcinoma of NSCLC Consumption and Growth Rate of Global Targeted Drugs for NSCLC Market

    • Table Global Targeted Drugs for NSCLC Market Import by Geography 2018-2023

    • Table Global Targeted Drugs for NSCLC Market Export by Geography 2018-2023

    • Table BeiGene - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table BeiGene - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Pfizer - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Pfizer - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Amgen - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Amgen - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table AstraZeneca - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table AstraZeneca - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Cipla - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Cipla - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Glenmark Pharmaceuticals - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Glenmark Pharmaceuticals - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Reliance Lifesciences - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Reliance Lifesciences - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Natco Pharma - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Natco Pharma - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Incepta Pharmaceuticals - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Incepta Pharmaceuticals - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Beacon Pharma Limited - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Beacon Pharma Limited - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Mylan - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Mylan - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Biocon - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Biocon - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Genvio Pharma Limited - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Genvio Pharma Limited - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Allergan - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Allergan - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Roche - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Roche - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Novartis - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Novartis - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table ARIAD Pharmaceuticals (Takeda) - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table ARIAD Pharmaceuticals (Takeda) - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Hetero Drugs - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Hetero Drugs - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Teva - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Teva - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table ImClone Systems ‎(Eli Lilly) - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table ImClone Systems ‎(Eli Lilly) - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table OSI Pharmaceuticals - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table OSI Pharmaceuticals - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Boehringer-Ingelheim - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Boehringer-Ingelheim - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Fujifilm Kyowa Kirin Biologics - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Fujifilm Kyowa Kirin Biologics - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Drug International Limted - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Drug International Limted - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Celgene Corporation - Company Snapshot

    • Table Business Operation (Consumption, Value, Price, Gross Margin) 2018-2023

    • Table Celgene Corporation - Company Products Benchmarking

    • Table Key Strategic Moves and Developments

    • Table Global Targeted Drugs for NSCLC Market Key Players Value 2018-2023

    • Table Global Targeted Drugs for NSCLC Market Key Players Value Share 2018-2023

    • Figure Global Targeted Drugs for NSCLC Market Concentration 2018 VS 2023

    • Table Market Strategy Analysis for Large Companies and Startups/ SMEs

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US